Houston, TX, United States of America

Juan Fueyo

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2008-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Juan Fueyo: Innovator in Cancer Treatment

Introduction

Juan Fueyo is a prominent inventor based in Houston, TX (US), known for his significant contributions to cancer treatment through innovative therapies. He holds a total of 4 patents, showcasing his dedication to advancing medical science and improving patient outcomes.

Latest Patents

Fueyo's latest patents focus on the development of oncolytic adenoviruses armed with therapeutic genes. These inventions involve compositions and methods for treating cancer using a mutant adenovirus that comprises a polynucleotide encoding a therapeutic polypeptide. This polypeptide is specifically targeted to cells with a mutant retinoblastoma pathway. The unique aspect of this mutant adenovirus is its ability to kill tumor cells while sparing those with a wild type retinoblastoma pathway, thus offering a promising approach to cancer therapy.

Career Highlights

Throughout his career, Juan Fueyo has worked with esteemed organizations such as the University of Texas System and Regeneron Pharmaceuticals, Inc. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.

Collaborations

Some of his notable coworkers include Candelaria Gomez-Manzano and W K Alfred Yung, who have played significant roles in advancing the research and development of cancer therapies alongside Fueyo.

Conclusion

Juan Fueyo's innovative work in the field of cancer treatment exemplifies the impact of dedicated inventors on medical science. His patents and collaborations highlight the importance of research in developing effective therapies for challenging diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…